The use of long-term low-molecular weight heparin for the treatment of venous thromboembolism in palliative care patients with advanced cancer: a case series of sixty two patients.

The use of long-term low-molecular weight heparin for the treatment of venous thromboembolism in palliative care patients with advanced cancer: a case series of sixty two patients.

Item
http://www.wikidata.org/entity/Q33376620
The potential benefits of low-molecular-weight heparins in cancer patientsPredictors of anticoagulation in hospice patients with lung cancer.Management of venous thromboembolism in patients with cancer: role of dalteparin.The challenges of managing cancer related venous thromboembolism in the palliative care settingManagement of venous thromboembolism in the palliative care setting.Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer.Cancer-associated thrombosis, low-molecular-weight heparin, and the patient experience: a qualitative studyA feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective anticoagulation length with low molecular weight heparin in the treatment of cancer associated thrombosis (ALICAT): study prHeparosan-derived heparan sulfate/heparin-like compounds: one kind of potential therapeutic agents.Barriers to the diagnosis and treatment of venous thromboembolism in advanced cancer patients: a qualitative study.
P2860

The use of long-term low-molecular weight heparin for the treatment of venous thromboembolism in palliative care patients with advanced cancer: a case series of sixty two patients.

Item
http://www.wikidata.org/entity/Q33376620
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
The use of long-term low-molec ...... series of sixty two patients.
@ast
The use of long-term low-molec ...... series of sixty two patients.
@en
type
label
The use of long-term low-molec ...... series of sixty two patients.
@ast
The use of long-term low-molec ...... series of sixty two patients.
@en
prefLabel
The use of long-term low-molec ...... series of sixty two patients.
@ast
The use of long-term low-molec ...... series of sixty two patients.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
The use of long-term low-molec ...... e series of sixty two patients
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698